marketcaparena
Search

    BBNX

    Beta Bionics, Inc.

    Company overview

    Market capitalization
    $923.19M
    Employees
    420
    Latest publication
    2026-09-29
    About Beta Bionics, Inc.

    Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Revenue32,013,000USD
    Cost Of Revenue13,111,000USD
    Gross Profit18,902,000USD
    Research Development10,240,000USD
    Selling And Marketing Expenses24,640,000USD
    General And Administrative Expenses9,600,000USD
    Total Operating Expenses44,480,000USD
    Operating Income-25,578,000USD
    Total Other Income Expense Net2,175,000USD
    Interest Income2,177,000USD
    Net Income-23,403,000USD
    SourceDisclosureDeterministicFinal

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20222022-12-31 · USD
    Total Revenue179,000USD
    Gross Profit179,000USD
    Research Development31,428,000USD
    Selling General Administrative24,668,000USD
    Selling And Marketing Expenses8,827,000USD
    Unclassified Operating Expenses1,100,000USD
    Total Operating Expenses66,023,000USD
    Operating Income-65,844,000USD
    Interest Income196,000USD
    Interest Expense14,000USD
    Net Interest Income182,000USD
    Income Before Tax-64,751,000USD
    Net Income-64,751,000USD
    Net Income From Continuing Ops-64,751,000USD
    Ebit-64,744,000USD
    Ebitda-63,399,000USD
    Depreciation And Amortization1,345,000USD
    Reconciled Depreciation2,087,000USD
    Total Other Income Expense Net1,093,000USD
    SourceLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets292,387,000USD304,417,000USD328,743,000USD330,046,000USD329,971,000USD338,024,000USD149,645,000USD96,938,000USD
    Cash And Equivalents44,318,000USD———————
    Cash And Short Term Investments180,489,000USD199,520,000USD219,125,000USD228,687,000USD249,720,000USD231,473,000USD103,575,000USD60,897,000USD
    Short Term Investments136,171,000USD169,314,000USD187,549,000USD190,202,000USD214,645,000USD189,019,000USD73,143,000USD43,416,000USD
    Long Term Investments44,648,000USD39,865,000USD45,431,000USD45,328,000USD31,149,000USD64,004,000USD0USD—
    Total Current Assets231,034,000USD247,986,000USD267,905,000USD270,026,000USD286,075,000USD261,915,000USD132,923,000USD82,555,000USD
    Other Current Assets8,474,000USD6,852,000USD7,164,000USD6,712,000USD5,600,000USD3,699,000USD4,032,000USD2,903,000USD
    Other Non Current Assets141,000USD———————
    Total Liabilities36,021,000USD———————
    Total Current Liabilities26,017,000USD23,191,000USD30,924,000USD25,388,000USD19,489,000USD16,492,000USD21,148,000USD17,879,000USD
    Other Non Current Liabilities1,629,000USD———————
    Total Stockholder Equity256,366,000USD271,245,000USD287,610,000USD294,760,000USD301,633,000USD313,752,000USD76,013,000USD32,866,000USD
    Total Equity Including Noncontrolling Interest256,366,000USD———————
    Deferred Revenue1,881,000USD———————
    Deferred Revenue Non Current3,454,000USD———————
    Net Receivables18,053,000USD17,887,000USD19,894,000USD14,254,000USD13,432,000USD11,013,000USD11,996,000USD7,464,000USD
    Inventory23,918,000USD23,727,000USD21,722,000USD20,373,000USD17,323,000USD15,730,000USD13,320,000USD11,291,000USD
    Property Plant Equipment Net16,564,000USD16,385,000USD15,227,000USD14,409,000USD12,503,000USD11,859,000USD11,421,000USD11,036,000USD
    Accounts Payable5,351,000USD2,318,000USD4,998,000USD4,461,000USD3,424,000USD3,454,000USD2,852,000USD2,848,000USD
    Short Term Debt1,591,000USD1,839,000USD1,938,000USD1,980,000USD1,519,000USD1,524,000USD1,529,000USD2,900,000USD
    Common Stock5,000USD5,000USD4,000USD4,000USD4,000USD4,000USD1,000USD1,000USD
    Retained Earnings-415,235,000USD-391,832,000USD-369,937,000USD-356,471,000USD-342,262,000USD-325,393,000USD-296,737,000USD-278,629,000USD
    Accumulated Other Comprehensive Income-390,000USD-96,000USD403,000USD354,000USD149,000USD240,000USD65,000USD58,000USD
    Total Liab—33,172,000USD41,133,000USD35,286,000USD28,338,000USD24,272,000USD73,632,000USD64,072,000USD
    Other Current Liab—17,329,000USD22,431,000USD17,605,000USD13,405,000USD10,565,000USD15,828,000USD13,031,000USD
    Capital Stock—5,000USD4,000USD4,000USD4,000USD4,000USD1,000USD1,000USD
    Cash—30,206,000USD31,576,000USD38,485,000USD35,075,000USD42,454,000USD30,432,000USD17,481,000USD
    Current Deferred Revenue—1,705,000USD1,557,000USD1,342,000USD1,141,000USD949,000USD939,000USD550,000USD
    Net Debt—-23,294,000USD-24,273,000USD-30,798,000USD-28,388,000USD-35,480,000USD-23,177,000USD-10,180,000USD
    Short Long Term Debt Total—6,912,000USD7,303,000USD7,687,000USD6,687,000USD6,974,000USD7,255,000USD7,301,000USD
    Property Plant Equipment Gross—22,725,000USD20,982,000USD20,697,000USD18,404,000USD17,415,000USD16,674,000USD16,059,000USD
    Common Stock Shares Outstanding—44,436,274shares40,529,051shares43,634,006shares43,390,652shares30,714,769shares43,348,840shares43,348,840shares
    Non Current Assets Total—56,431,000USD60,838,000USD60,020,000USD43,896,000USD76,109,000USD16,722,000USD14,382,999USD
    Non Current Liabilities Total—9,981,000USD10,209,000USD9,898,000USD8,849,000USD7,780,000USD52,484,000USD46,193,000USD
    Non Current Liabilities Other—1,558,000USD1,547,000USD1,205,000USD1,011,000USD———
    Non Currrent Assets Other—181,000USD180,000USD283,000USD244,000USD246,000USD5,301,000USD3,246,999USD
    Net Working Capital—224,795,000USD236,981,000USD244,638,000USD266,586,000USD245,423,000USD111,775,000USD64,676,000USD
    Unclassified Non Current Liabilities—8,423,000USD8,662,000USD8,693,000USD7,838,000USD7,780,000USD52,484,000USD46,193,000USD
    Unclassified Equity—663,163,000USD657,136,000USD650,869,000USD643,738,000USD638,897,000USD372,683,000USD311,435,000USD
    Unclassified Current Liabilities———————-1,450,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Assets328,743,000USD149,645,000USD110,040,000USD35,527,000USD
    Other Current Assets7,164,000USD4,032,000USD1,183,000USD792,000USD
    Total Liab41,133,000USD73,632,000USD51,432,000USD22,527,000USD
    Total Stockholder Equity287,610,000USD76,013,000USD58,608,000USD13,000,000USD
    Other Current Liab22,431,000USD15,828,000USD8,215,000USD7,467,000USD
    Common Stock4,000USD1,000USD1,000USD1,000USD
    Capital Stock4,000USD1,000USD1,000USD1,000USD
    Retained Earnings-369,937,000USD-296,737,000USD-229,664,000USD-185,565,000USD
    Cash31,576,000USD30,432,000USD26,566,000USD27,675,000USD
    Cash And Short Term Investments219,125,000USD103,575,000USD96,745,000USD27,675,000USD
    Total Current Assets267,905,000USD132,923,000USD103,621,000USD28,467,000USD
    Total Current Liabilities30,924,000USD21,148,000USD10,605,000USD8,873,000USD
    Current Deferred Revenue1,557,000USD939,000USD87,000USD—
    Net Debt-24,273,000USD-23,177,000USD-22,343,000USD-23,542,000USD
    Short Term Debt1,938,000USD1,529,000USD1,224,000USD976,000USD
    Short Long Term Debt Total7,303,000USD7,255,000USD4,223,000USD4,133,000USD
    Long Term Investments45,431,000USD0USD——
    Short Term Investments187,549,000USD73,143,000USD70,179,000USD0USD
    Net Receivables19,894,000USD11,996,000USD4,448,000USD0USD
    Inventory21,722,000USD13,320,000USD1,245,000USD0USD
    Accounts Payable4,998,000USD2,852,000USD1,166,000USD430,000USD
    Property Plant Equipment Net15,227,000USD11,421,000USD6,198,000USD6,867,000USD
    Property Plant Equipment Gross20,982,000USD16,674,000USD10,618,000USD10,241,000USD
    Accumulated Other Comprehensive Income403,000USD65,000USD137,000USD—
    Common Stock Shares Outstanding40,529,051shares6,365,064shares5,303,684shares4,997,524shares
    Non Current Assets Total60,838,000USD16,722,000USD6,419,000USD7,060,000USD
    Non Current Liabilities Total10,209,000USD52,484,000USD40,827,000USD13,654,000USD
    Non Current Liabilities Other1,547,000USD———
    Non Currrent Assets Other180,000USD5,301,000USD221,000USD193,000USD
    Net Working Capital236,981,000USD111,775,000USD93,016,000USD19,594,000USD
    Unclassified Non Current Liabilities8,662,000USD52,484,000USD40,827,000USD13,654,000USD
    Unclassified Equity657,136,000USD372,683,000USD288,133,000USD198,563,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-21,895,000USD-13,466,000USD-14,209,000USD-16,869,000USD-28,656,000USD-18,108,000USD-9,736,000USD-14,463,000USD
    Depreciation671,000USD935,000USD683,000USD653,000USD604,000USD529,000USD615,000USD576,000USD
    Stock Based Compensation5,406,000USD4,303,000USD4,478,000USD4,799,000USD2,804,000USD1,551,000USD1,976,000USD1,499,000USD
    Other Non Cash Items200,000USD939,000USD2,000USD-678,000USD11,745,000USD4,992,000USD1,461,000USD2,837,000USD
    Change To Account Receivables1,368,000USD-5,595,000USD-168,000USD-2,335,000USD2,936,000USD-4,558,000USD1,496,000USD-2,638,000USD
    Change To Inventory-1,803,000USD-2,203,000USD-3,327,000USD-1,729,000USD-2,621,000USD-1,577,000USD-3,561,000USD-3,894,000USD
    Change In Working Capital-8,214,000USD-1,338,000USD317,000USD-1,499,000USD-6,472,000USD-3,243,000USD-1,338,000USD-2,686,000USD
    Total Cash From Operating Activities-23,832,000USD-8,627,000USD-8,729,000USD-13,594,000USD-19,975,000USD-14,279,000USD-9,613,000USD-12,237,000USD
    Capital Expenditures-1,377,000USD-1,903,000USD-1,282,000USD-1,779,000USD-333,000USD-561,000USD-1,921,000USD-507,000USD
    Free Cash Flow-25,209,000USD-10,530,000USD-10,011,000USD-15,373,000USD-20,308,000USD-14,840,000USD-11,534,000USD-12,744,000USD
    Investments23,216,000USD2,561,000USD9,486,000USD6,173,000USD-179,122,000USD-29,662,000USD15,242,000USD3,300,000USD
    Total Cashflows From Investing Activities21,839,000USD658,000USD9,486,000USD6,173,000USD-179,122,000USD-29,662,000USD15,242,000USD3,300,000USD
    Total Cash From Financing Activities623,000USD1,060,000USD2,653,000USD42,000USD211,119,000USD56,892,000USD-1,176,000USD-107,000USD
    Issuance Of Capital Stock0USD-904,000USD0USD0USD211,021,000USD59,660,000USD0USD0USD
    Change In Cash-1,370,000USD-6,909,000USD3,410,000USD-7,379,000USD12,022,000USD12,951,000USD17,481,000USD-9,043,000USD
    Begin Period Cash Flow31,676,000USD38,585,000USD35,175,000USD42,554,000USD30,532,000USD17,581,000USD13,129,000USD22,172,000USD
    End Period Cash Flow30,306,000USD31,676,000USD38,585,000USD35,175,000USD42,554,000USD30,532,000USD17,481,000USD13,129,000USD
    Unclassified Financing Cash Flow—1,964,000USD2,653,000USD——-59,660,000USD-1,295,000USD—
    Unclassified Investing Cash Flow——1,282,000USD1,779,000USD—29,662,000USD1,921,000USD—
    Other Cashflows From Financing Activities————98,000USD56,892,000USD119,000USD-119,000USD
    Other Cashflows From Investing Activities—————-29,101,000USD——
    Unclassified Operating Cash Flow——————-2,591,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Net Income-73,200,000USD-54,756,000USD-44,099,000USD-64,751,000USD
    Depreciation2,875,000USD2,283,000USD2,091,000USD2,087,000USD
    Stock Based Compensation16,384,000USD6,384,000USD5,658,000USD6,100,000USD
    Other Non Cash Items12,008,000USD9,964,000USD10,268,000USD-854,000USD
    Change To Account Receivables-5,162,000USD-7,618,000USD-4,494,000USD0USD
    Change To Inventory-9,880,000USD-11,439,000USD-1,187,000USD0USD
    Change In Working Capital-8,992,000USD-12,148,000USD-6,363,000USD-2,790,000USD
    Total Cash From Operating Activities-50,925,000USD-48,273,000USD-32,445,000USD-60,208,000USD
    Capital Expenditures-5,297,000USD-3,395,000USD-402,000USD-772,000USD
    Free Cash Flow-56,222,000USD-51,668,000USD-32,847,000USD-60,980,000USD
    Investments-157,508,000USD-3,476,000USD-69,693,000USD-769,000USD
    Total Cashflows From Investing Activities-162,805,000USD-3,476,000USD-69,693,000USD-769,000USD
    Total Cash From Financing Activities214,874,000USD55,615,000USD101,029,000USD56,782,000USD
    Issuance Of Capital Stock210,117,000USD59,660,000USD101,000,000USD56,393,000USD
    Change In Cash1,144,000USD3,866,000USD-1,109,000USD-4,195,000USD
    Begin Period Cash Flow30,532,000USD26,666,000USD27,775,000USD31,970,000USD
    End Period Cash Flow31,676,000USD30,532,000USD26,666,000USD27,775,000USD
    Unclassified Financing Cash Flow4,757,000USD-63,705,000USD-101,000,000USD-56,393,000USD
    Other Cashflows From Investing Activities—50,000USD-69,291,000USD3,000USD
    Other Cashflows From Financing Activities—59,660,000USD101,029,000USD56,782,000USD
    Unclassified Investing Cash Flow—3,345,000USD69,693,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductILet12,872,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductSingle Use Products19,141,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductILet10,554,000USD0001193125-26-166843
    Q1 2026Quarterly · 2026-03-31ProductSingle Use Products17,072,000USD0001193125-26-166843
    Q4 2025Quarterly · 2025-12-31ProductILet14,671,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductSingle Use Products17,450,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductILet52,747,000USD0001193125-26-067065
    FY 2025Yearly · 2025-12-31ProductSingle Use Products47,504,000USD0001193125-26-067065
    Q3 2025Quarterly · 2025-09-30ProductILet14,323,000USD0001193125-25-253538
    Q3 2025Quarterly · 2025-09-30ProductSingle Use Products12,930,000USD0001193125-25-253538
    Q2 2025Quarterly · 2025-06-30ProductILet13,619,000USD0000950170-25-099652
    Q2 2025Quarterly · 2025-06-30ProductSingle Use Products9,619,000USD0000950170-25-099652
    Q1 2025Quarterly · 2025-03-31ProductILet10,134,000USD0001193125-26-166843
    Q1 2025Quarterly · 2025-03-31ProductSingle Use Products7,505,000USD0001193125-26-166843
    Q4 2024Quarterly · 2024-12-31ProductILet13,863,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductSingle Use Products6,577,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductILet48,716,000USD0001193125-26-067065
    FY 2024Yearly · 2024-12-31ProductSingle Use Products16,408,000USD0001193125-26-067065
    Q3 2024Quarterly · 2024-09-30ProductILet12,270,000USD0001193125-25-253538
    Q3 2024Quarterly · 2024-09-30ProductSingle Use Products4,435,000USD0001193125-25-253538
    FY 2023Yearly · 2023-12-31ProductILet10,704,000USD0000950170-25-044516
    FY 2023Yearly · 2023-12-31ProductSingle Use Products1,291,000USD0000950170-25-044516

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.